Prenatal Vaccination With RSV Prefusion F Does Not Increase Risk for Preterm Birth
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 12, 2024 -- Prenatal vaccination with a nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) protein subunit vaccine is not associated with an increased risk for preterm birth (PTB), according to a study published online July 8 in JAMA Network Open.
In a retrospective observational cohort study, Moeun Son, M.D., from the Weill Cornell Medical College in New York City, and colleagues examined the association between prenatal RSV vaccination status and perinatal outcomes among patients who delivered during the vaccination season. Data were included for 2,973 pregnant individuals, 34.5 percent of whom received prenatal RSVpreF vaccination.
The researchers found that 60 patients who had evidence of prenatal vaccination experienced PTB compared with 131 of those without evidence of prenatal vaccination (5.9 versus 6.7 percent). There was no association seen for prenatal vaccination with an increased risk for PTB after adjustment for potential confounding variables and addressing immortal time bias. Pregnancy and neonatal outcomes did not differ significantly based on vaccination status, but an increased risk for hypertensive disorders of pregnancy was seen in the time-dependent model.
"In the main analyses, there were no significant differences in maternal or perinatal outcomes between patients who had electronic health record evidence of prenatal RSVpreF vaccination and those who did not," the authors write.
Two authors disclosed ties to Pfizer, the manufacturer of the RSVpreF vaccine.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 01:15
Read more
- Recreational Cannabis Legalization Tied to Higher Prenatal Use
- FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
- Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- Greater Fine Particulate Matter Linked to Increased Odds of Eczema
- Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
- Online Yoga Classes Can Ease Lower Back Pain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions